SENS Stock: Senseonics acquires new patent

On Thursday, May 13th, 2021, Senseonics a company that engages in design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application just had their patent approved for skin sensitivity and rash detector.

This new patent allows the use of systems, methods, and devices such as an external devices, for determining the condition of a skin surface covered by an adhesive patch, light source which can be implantable in the skin, a controller and a photodetector.

The patent can be viewed here